Literature DB >> 27601806

Prevalence and characterization of opportunistic candidal infections among patients with pulmonary tuberculosis.

Madhusudan Astekar1, Priyanka Sharma Bhatiya2, G V Sowmya3.   

Abstract

BACKGROUND: Although Candida albicans remains the most common cause of human candidiasis, the frequency of infection attributed to other members of the genus is also increasing. Hence, the present study was carried out to know the prevalence of opportunistic candidal infection in tuberculosis, and if positive, the species of Candida that is most commonly associated.
MATERIALS AND METHODS: The present study comprised sixty pulmonary tuberculosis patients who were divided into (1) fresh or untreated group, (2A) chronic or treated group having no complications and (2B) having complications, comprising twenty patients each, respectively. The collected sputum samples were initially stained with Ziehl-Neelsen stain for confirmation of presence of tubercle Bacilli. Primary isolation was done on Sabouraud Dextrose Agar (SDA). The candidal colonies were confirmed microscopically for the presence of pseudohyphae. Further speciation of the positive candidal samples was carried out using ChromAgar. RESULT: The total fungal prevalence among 60 patients with pulmonary tuberculosis on SDA was 33 (55%) Candida and 3 (5%) Aspergillus. The prevalence of different candidal species on ChromAgar showed C. albicans as the predominant one, followed by Candida tropicalis and Candida krusei. Freshly diagnosed or untreated group was less commonly associated with pulmonary mycoses than chronic or treated group. The prevalence of Candida had increased with treatment, duration and age, and it was more in males than females.
CONCLUSION: The present study confirms the phenomenon of opportunistic candidal infections in pulmonary tuberculosis patients. Rapid and reliable identification of Candida species is essential as they differ in their virulence and sensitivity to antifungal drugs.

Entities:  

Keywords:  Antifungal drugs; Candida; ChromAgar; opportunistic infections; pulmonary tuberculosis

Year:  2016        PMID: 27601806      PMCID: PMC4989544          DOI: 10.4103/0973-029X.185913

Source DB:  PubMed          Journal:  J Oral Maxillofac Pathol        ISSN: 0973-029X


  8 in total

1.  Pulmonary mycoses occurring in Britain.

Authors:  R W RIDDELL; Y M CLAYTON
Journal:  Br J Tuberc Dis Chest       Date:  1958-01

Review 2.  Tuberculosis: epidemiology, manifestations, and the value of medical imaging in diagnosis.

Authors:  A I De Backer; K J Mortelé; B L De Keulenaer; P M Parizel
Journal:  JBR-BTR       Date:  2006 Sep-Oct

3.  Respiratory and systemic mycoses: an overview.

Authors:  H S Randhawa
Journal:  Indian J Chest Dis Allied Sci       Date:  2000 Oct-Dec

4.  Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations.

Authors:  Jean-Philippe Bouchara; Philippe Declerck; Bernard Cimon; Claire Planchenault; Ludovic de Gentile; Dominique Chabasse
Journal:  Clin Microbiol Infect       Date:  1996-02       Impact factor: 8.067

Review 5.  Epidemiology of tuberculosis: current status in India.

Authors:  A K Chakraborty
Journal:  Indian J Med Res       Date:  2004-10       Impact factor: 2.375

6.  Identification of chlamydospore-negative Candida albicans using CHROMagar Candida medium.

Authors:  R Fotedar; S S al-Hedaithy
Journal:  Mycoses       Date:  2003-04       Impact factor: 4.377

7.  Characterization of Candida species isolated from cases of lower respiratory tract infection.

Authors:  B J Jha; S Dey; M D Tamang; M E Joshy; P G Shivananda; K N Brahmadatan
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2006 Jul-Sep

8.  Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings.

Authors:  Sayyada Ghufrana Nadeem; Shazia Tabassum Hakim; Shahana Urooj Kazmi
Journal:  Libyan J Med       Date:  2010-02-09       Impact factor: 1.657

  8 in total
  2 in total

1.  The Efficacy and Safety of Surgical Treatment for Patients With Tuberculosis Destroyed Lung With or Without Chronic Pulmonary Aspergillosis.

Authors:  Hongyun Ruan; Changfan Gong; Jinxiang Wang
Journal:  World J Surg       Date:  2021-02-08       Impact factor: 3.352

2.  Status of pulmonary fungal pathogens among individuals with clinical features of pulmonary tuberculosis at Mbarara University Teaching Hospital in Southwestern Uganda.

Authors:  Israel Kiiza Njovu; Benson Musinguzi; James Mwesigye; Kennedy Kassaza; Joseph Turigurwa; Edwin Nuwagira; Joel Bazira; Taseera Kabanda; Moses Mpeirwe; Lucas Ampaire; Andrew Mutekanga; James Kiguli; Beatrice Achan; Herbert Itabangi
Journal:  Ther Adv Infect Dis       Date:  2021-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.